Equities

Twist Bioscience Corp

Twist Bioscience Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)42.23
  • Today's Change0.57 / 1.37%
  • Shares traded717.52k
  • 1 Year change+77.36%
  • Beta1.7797
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Sep 30 2024202420232022
ASSETS
Cash And Short Term Investments276336505
Total Receivables, Net354440
Total Inventory243239
Prepaid expenses111212
Other current assets, total------
Total current assets347424596
Property, plant & equipment, net161203214
Goodwill, net868686
Intangibles, net145460
Long term investments------
Note receivable - long term------
Other long term assets3.095.683.39
Total assets614776961
LIABILITIES
Accounts payable1.631420
Accrued expenses645151
Notes payable/short-term debt000
Current portion long-term debt/capital leases----0
Other current liabilities, total5.827.8020
Total current liabilities717391
Total long term debt000
Total debt000
Deferred income tax------
Minority interest------
Other liabilities, total718081
Total liabilities142153172
SHAREHOLDERS EQUITY
Common stock0.000.000
Additional paid-in capital1,7151,6571,620
Retained earnings (accumulated deficit)(1242)(1033)(828)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(0.52)(0.76)(1.84)
Total equity473623789
Total liabilities & shareholders' equity614776961
Total common shares outstanding595857
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.